Keisha Jones is the head of recruitment of clinical trials for Sanders-Brown, and she’s trying reach more people of color.
“These are my people! We’re gonna talk. We’re gonna talk about those things, and those hard questions, and those hard conversations,” says Jones. Talking about dementia, and the trials necessary to advance research on it, can be hard. There are historical barriers. “Tuskegee and Henrietta Lacks, those are some of the things a lot of us know about where those practices were not protecting human subjects,” explains Jones.
Angela Holloman identifies other barriers.
“There are certain things, certain social determinates of health like access to doctors, access to medications, availability of fresh foods, that can contribute to one’s health and those things do play a role in the development of vascular demetia and Alzheimer’s,” notes Holloman. “If they’re still working or caring for loved ones, time can be an issue. Transportation can be an issue, or just knowing that these resources and clinical trials are available.”
To watch the WKYT News Video, click here.